Is Hurthle cell thyroid cancer curable?
Hurthle cell cancer is usually very curable if you have an expert team of doctors in your initial treatment. A high resolution ultrasound and expert surgery is critical in the management of Hurthle cell thyroid cancer. Choosing the right team and the best surgeon is your most important step in curing your cancer.
Where does hurthle cell cancer spread to?
Follicular cancer tends to spread through the bloodstream and although it is uncommon, can spread (i.e. metastasize) to the liver, lungs, bones, and brain. Hurthle cell cancers can spread through the blood or to the lymph nodes, but fortunately, metastasis is uncommon.
Is Hurthle cell carcinoma a differentiated thyroid cancer?
Papillary, follicular, and medullary carcinomas comprised the differentiated type of thyroid neoplasms. Hurthle cell carcinoma (HCC) of the thyroid gland is one of the lesser-known thyroid cancer types. It used to be considered a variant of follicular thyroid cancer.
Is Hurthle cell carcinoma rare?
Hurthle cell adenocarcinoma is a rare invasive thyroid malignancy, accounting for 3 to 4% of all thyroid malignancies. Compared to differentiated thyroid carcinoma, HCC has high risk of lymph node metastasis and distant metastasis and is less sensitive to radioiodine therapy [4, 5].
Is Hurthle cell carcinoma fast growing?
The most common physical sign of Hürthle cell carcinoma is a quickly growing lump that you can feel below your Adam’s apple. Other signs may include difficulty swallowing, pain, a hoarse voice if the vocal cords are involved, pressing down of the trachea, and enlarged lymph nodes.
Is Hurthle cell carcinoma well differentiated?
WELL-DIFFERENTIATED thyroid carcinomas are the most common endocrine malignancies. Hürthle cell carcinomas account for approximately 5% of well-differentiated thyroid carcinomas, and some debate has emerged regarding the classification of Hürthle cell carcinomas.
What percentage of Hurthle cell neoplasms are malignant?
Results: The overall rate of malignancy in patients with Hürthle cell neoplasms was 21%. The average tumor size was 3.2 cm, with malignant tumors being significantly larger than benign tumors (5.0 vs. 2.7 cm, p<0.01).
What causes Hurthle cell?
What causes Hurthle cell carcinoma (HCC)? The exact cause of HCC is unknown. Doctors associate several risk factors with the disease, including: Exposure to radiation from X-rays or medical treatments like radiation therapy for cancer.
What is the staging system for Hurthle cell cancer?
This staging system for hurthle cell cancer takes into account the age of the patient. The staging system also includes the size of the hurthle cell cancer in the thyroid gland itself and whether or not the cancer has spread into lymph nodes around the thyroid or sides of the neck.
How is thyroid Hurthle cell cancer staged?
Thyroid hurthle cell cancer has a staging system that is not like other cancers. This staging system for hurthle cell cancer takes into account the age of the patient. The current break point of age in the American Joint Committee on Cancer (AJCC) staging system for both follicular and papillary thyroid cancer is 45 years of age.
How should I think about Hurthle cell cancer?
Try not to think about hurthle cell cancer as you would other thyroid cancers, since this assumption will likely lead you to decisions that are not necessarily justified. Hurthle cell cancer typically starts within the thyroid as growth, or bump (nodule) in the thyroid that grows out of the otherwise normal thyroid tissue.
Can Hurthle cell cancer spread to lymph nodes?
Hurthle cell cancer has a greater risk of growing into blood vessels in and around the thyroid. This is called angioinvasion. This occurs, in fact, more frequently than hurthle cell cancer spreads to lymph nodes.